Volume : 09, Issue : 11, November – 2022

Title:

33.AN OVERVIEW OF MECHANISMS OF ANTIBIOTIC RESISTANCE IN BACTERIA
‬

Authors :

Jehad Ahmed Alluhaybi*, Hisham Ayidh Alharbi, Ahmed Saeed Alghamdi, Yaser Abdullah Alqurashi, Faisal Fahad Alsharif, Abdullah Ali Alshehri, Muath Abdullah Hadayidi, Yaser Mishal Alharthi, Sami Ali Hasan, Rami Mohammed Dada

Abstract :

The purpose of this review was to highlight the most significant parts of antibiotic resistance mechanisms. In addition, we endeavored to address the advantages of antibiotics as well as the resistance challenge. We conducted a comprehensive literature evaluation on antibiotics resistance by an electronic search of MIDLINE, EMBASE, and Google Scholar databases up to April 2022. For the purpose of analyzing the mechanism of antibiotic resistance, we picked the most significant papers pertinent to our area of inquiry. The value and importance of antibiotics cannot be overestimated; we rely on them solely for the treatment of infectious diseases, and they must never be considered fundamental products. Antibiotics are essential to the success of cutting-edge surgical procedures, such as organ and prosthesis transplants, in addition to their use in the treatment of communicable diseases. There is little doubt that the situation in regards to antibiotic resistance is dire, despite all good intentions to restrict antibiotic consumption (albeit limited activity). Resistance mechanisms are widespread and cause considerable clinical and monetary concerns for healthcare systems globally. There are no universal solutions to the problem. Even when lives can be saved, decisive actions requiring significant commitment and enforcement are never emphasized. It is crucial that we have a good picture of the amount of different resistance systems that private bacteria may possess.

Cite This Article:

Please cite this article in press Jehad Ahmed Alluhaybi et al, An Overview Of Mechanisms Of Antibiotic Resistance In Bacteria.,Indo Am. J. P. Sci, 2022; 09(11).

Number of Downloads : 10

References:

1. Waksman S. A. (1961). The role of antibiotics in nature. Perspect. Biol. Med. 4 271–286
2. Gullberg E., Cao S., Berg O G., Illback C., Sandegren L., Hughes D., et al. (2011). Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 7:e100215810.1371/journal.ppat.1002158
3. Davies J. (2009). Darwin and microbiomes. EMBO Rep. 10 805
4. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018;4(3):482-501. Published 2018 Jun 26. doi:10.3934/microbiol.2018.3.482
5. Golkar Z, Bagazra O, Pace DG. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis. J Infect Dev Ctries. 2014;8(2):129–136. 13.
6. Gould IM, Bal AM. New antibiotic agents in the pipeline and how they can overcome microbial resistance. Virulence. 2013;4(2):185–191.
7. Wright GD. Something new: revisiting natural products in antibiotic drug discovery. Can J Microbiol. 2014;60(3):147–154.
8. Sengupta S, Chattopadhyay MK, Grossart HP. The multifaceted roles of antibiotics and antibiotic resistance in nature. Front Microbiol. 2013;4:47.
9. Spellberg B, Gilbert DN. The future of antibiotics and resistance: a tribute to a career of leadership by John Bartlett. Clin Infect Dis. 2014;59 (suppl 2):S71–S75.
10. Viswanathan VK. Off-label abuse of antibiotics by bacteria. Gut Microbes. 2014;5(1):3–4.
11. Read AF, Day T, Huijben S. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(Suppl 2):10871-10877. doi:10.1073/pnas.1100299108.
12. Abraham, E. P., and E. Chain. 1940. An enzyme from bacteria able to destroy penicillin. Rev. Infect. Dis. 10:677-678.
13. Wright, G. D., and M. Morar. The genomic enzymology of antibiotic resistance. Annu. Rev. Genet., in press.
14. D’Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright. 2006. Sampling the antibiotic resistome. Science 311:374-377.
15. Allen, H. K., J. Donato, H. H. Wang, K. A. Cloud-Hansen, J. E. Davies, and J. Handelsman. 2010. Call of the wild: antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. 8:251-259.
16. Gale, E. F., E. Cundliffe, P. E. Reynolds, M. H. Richmond, and M. J. Waring (ed.). 1981. The molecular basis of antibiotic action, 2nd ed. John Wiley, Chichester, United Kingdom.
17. Walsh, C. 2003. Antibiotics: actions, origins, resistance. ASM Press, Washington, DC.
18. Marshall, B. M., D. J. Ochieng, and S. B. Levy. 2009. Commensals: unappreciated reservoir of antibiotic resistance. Microbe 4:231-238.
19. Piddock LJ. The crisis of no new antibiotics—what is the way forward? Lancet Infect Dis. 2012;12(3):249–253.
20. Rossolini GM, Arena F, Pecile P, Pollini S. Update on the antibiotic resistance crisis. Clin Opin Pharmacol. 2014;18:56–60.
21. Kashmiri, S. V. S., and R. D. Hotchkiss. 1975. Evidence of tandem duplication of genes in a merodiploid region of pneumococcal mutants resistant to sulfonamide. Genetics 81:21.
22. Brochet, M., E. Couvé, M. Zouine, C. Poyart, and P. Glaser. 2008. A naturally occurring gene amplification leading to sulfonamide and trimethoprim resistance in Streptococcus agalactiae. J. Bacteriol.190:672-680.
23. WHO (World Health Organization): Antimicrobial Resistance: Global Report on surveillance. 2014 http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf.
24. Boucher H, Miller LG, Razonable RR: Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2010, 51(Suppl. 2):S183-S197.
25. Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P et al.: Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 2011, 38:331-335.
26. ECDC: European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network. 2013.
27. David MZ, Daum RS, Bayer AS, Chambers HF, Fowler VG, Miller LG, Ostrowsky B, Baesa A, Boyle-Vavra S, Eells SJ et al.: Staphylococcus aureus bacteremia at five U.S. academic medical centers, 2008–2011: significant geographic variation in community-onset infections. Clin Infect Dis 2014 http:// dx.doi.org/10.1093/cid/ciu410.
28. Chen C-J, Huang Y-C: New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect 2014:1270 http:// dx.doi.org/10.1111/1469-0691.5.
29. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, Duckworth G: Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012, 67:802-809.
30. Kurosu M, Siricilla S, Mitachi K: Advances in MRSA drug discovery: where are we and where do we need to be? Expert Opin Drug Discov 2013, 8:1095-1116. 14. Sader HS,
31. Farrell DJ, Flamm RK, Jones RN: Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005–2012). Int J Antimicrob Agents 2014, 43:465-469.
32. Alm RA, McLaughlin RE, Kos VN, Sader HS, Iaconis JP, Lahiri SD: Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective. J Antimicrob Chemother 2014 http:// dx.doi.org/10.1093/jac/dku114.
33. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al.: Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
34. Livermore DM: Current epidemiology and growing resistance of Gram-negative pathogens. Korean J Intern Med 2012, 27:128-142.
35. Pendleton JN, Gorman SP, Gilmore BF: Clinical relevance of the ESKAPE pathogens. Expert Rev Anti Infect Ther 2013, 11:297-308.